Head-to-head · WeighScore
Andrew Meds vs Breeze Meds
By GLP-1 ScorecardUpdated
Score comparison
Breeze Meds has the higher recorded score — 72.4/100 to 67.1/100.
Breeze Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Charges nothing until a provider approves you — but keeps its pricing inside the intake.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Andrew Meds | Breeze Meds |
|---|---|---|
| WeighScore | 67.1/100 | 72.4/100 |
| Grade | C | C |
| Site position | #188 | #90 |
| Semaglutide | $199/mo (product page; two live intake funnels price semaglutide differently) | From $199/mo |
| Tirzepatide | $299/mo (product page; neither GLP-1 funnel offered tirzepatide when walked) | From $299/mo first month, $399/mo thereafter |
| Coverage | All 50 states plus Washington, D.C. | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #188 · C
Strengths
- States its compounding class in plain language on the product pages — a 503(A) pharmacy or a 503(B) outsourcing facility — which most of the field leaves unstated
- Names the prescribing practice in the footer of every page
- Prices sit on the product pages before any intake, and free expedited shipping is stated rather than added at checkout
- Serves all 50 states and the District of Columbia, stated in the footer without a hedge
What to consider
- Three live semaglutide figures the site never reconciles: $199 a month on the product page, $99 a month in the microdosing funnel, and $149 for a four-week supply in the second funnel
- Every Get Started button on the compounded semaglutide page lands on a microdosing intake, which is a different program from the one the page describes
- Both GLP-1 intakes ended offering only semaglutide, so whether tirzepatide can be bought through the current funnels is unclear
- The funnel promises a 100% success guarantee and a money-back weight-loss guarantee while the Terms say refunds are not offered for partially used subscription periods
- The pharmacy class is stated but no pharmacy is named, and no individual clinician or NPI appears anywhere
- An oral tirzepatide product is advertised on both GLP-1 pages and every link to it resolves to a page that does not list it
Site position #90 · C
Strengths
- Nothing charged until a provider approves you, and the consult is free if you go ahead
- One inclusive price covering consult, medication, supplies, shipping and support
- LegitScript certified, all 50 states, cancel or change plan at any time
- NAD+ injections offered alongside the GLP-1 line
What to consider
- The public site names no molecule behind its "from $199" — tirzepatide pricing appears only inside the intake
- Every quoted figure is for the LOWEST dose; the funnel says higher doses may cost more
- An $80 consultation fee applies if you are approved and then decline
- Injection only, compounded only, with no published lab program
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.